Abstract:Objectives: Accurate glomerular filtration rate (GFR) assessment is essential in critically ill patients. GFR is often estimated using creatinine-based equations, which require surrogates for muscle mass such as age and sex. Race has also been included in GFR equations, based on the assumption that Black individuals have genetically determined higher muscle mass. However, race-based GFR estimation has been questioned with the recognition that race is a poor surrogate for genetic ancestry, and racial health disparities are driven largely by socioeconomic factors. The American Society of Nephrology and the National Kidney Foundation (ASN/NKF) recommend widespread adoption of new “race-free” creatinine equations, and increased use of cystatin C as a race-agnostic GFR biomarker. Data Sources: Literature review and expert consensus. Study Selection: English language publications evaluating GFR assessment and racial disparities. Data Extraction: We provide an overview of the ASN/NKF recommendations. We then apply an Implementation science methodology to identify facilitators and barriers to implementation of the ASN/NKF recommendations into critical care settings and identify evidence-based implementation strategies. Last, we highlight research priorities for advancing GFR estimation in critically ill patients. Data Synthesis: Implementation of the new creatinine-based GFR equation is facilitated by low cost and relative ease of incorporation into electronic health records. The key barrier to implementation is a lack of direct evidence in critically ill patients. Additional barriers to implementing cystatin C-based GFR estimation include higher cost and lack of test availability in most laboratories. Further, cystatin C concentrations are influenced by inflammation, which complicates interpretation. Conclusions: The lack of direct evidence in critically ill patients is a key barrier to broad implementation of newly developed “race-free” GFR equations. Additional research evaluating GFR equations in critically ill patients and novel approaches to dynamic kidney function estimation is required to advance equitable GFR assessment in this vulnerable population.

Race and the False Precision of Glomerular Filtration Rate Estimates

[Clinical implications of the estimated glomerular filtration rate]

Glomerular filtration rate measurement and estimation in chronic kidney disease

The methods for measuring glomerular filtration rate and their clinical application

Estimating and measuring glomerular filtration rate: methods of measurement and markers for estimation

[Estimation of glomerular filtration rate with creatinine]

How to Assess the Glomerular Filtration Rate, and Which Method is Deemed Most Reliable?

Measured and estimated glomerular filtration rate: current status and future directions

Assessment of kidney function: clinical indications for measured GFR

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Measured Glomerular Filtration Rate: The Query for a Workable Golden Standard Technique

Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation

[New developments and future prospects in the field of glomerular filtration rate estimation]

Toward Equitable Kidney Function Estimation in Critical Care Practice. Guidance From the Society of Critical Care Medicine’s Diversity, Equity, and Inclusion in Renal Clinical Practice Task Force

Glomerular Filtration Rate Estimation in Adults: Myths and Promises

Features of methods of glomerular filtration rate estimation

Estimated glomerular filtration rate in observational and interventional studies in chronic kidney disease

Glomerular Filtration Rate Assessment in Children

Estimating kidney function in the critically ill patients

Single- versus multiple-sample method to measure glomerular filtration rate

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate